Company Recognized for Innovation in Developing ForsLean® Ingredient
PISCATAWAY, NJ, August 31, 2004 -- Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded the Research & Development Council of New Jersey's 2004 Thomas Alva Edison Patent Award in the Consumer/Small Company category for its U.S. Patent #5,804,596, method of preparing a forskolin composition for use in promoting lean body mass and treating mood disorders. The Thomas Alva Edison Patent Awards, which recognize the most revolutionary product innovations and important scientific breakthroughs originating in New Jersey, will be presented at the Council's annual fall dinner on November 11, 2004, at the Liberty Science Center in Jersey City, NJ.
"We strongly believe in our ForsLean ingredient, the forskolin composition supported by this patent, and its ability to safely and effectively help individuals increase their lean body mass and improve overall health," stated Dr. Muhammed Majeed, founder and CEO, Sabinsa Corporation. "Sabinsa was founded on the premise of creating innovative products through state of the art research, and this award is a testament to the company's ongoing efforts in this area."
Companies throughout New Jersey were invited to submit patents for consideration for the Thomas Alva Edison Patent Awards. Each patent was reviewed thoroughly by the Council, which is comprised of senior representatives from industry, academia and government. Winners were then chosen based on their exceptional merit. Other 2004 award winners include Celgene Corporation, Engelhard Corporation, ExxonMobil Research & Engineering, International Specialty Products, Merck & Co., Inc., Princeton University, Rutgers University, Schering-Plough Research Institute and Wyeth to name a few.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of high quality herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Over the past nine years, Sabinsa has brought to market more than thirty standardized botanical extracts, including ForsLean. ForsLean is an extract of Coleus forskohlii root, which contains high levels of forskolin, a compound that has been shown to increase lean body mass and promote weight loss. Sabinsa has secured a patent for the use of forskolin as a weight management ingredient and manufactures and supplies various extract strengths for use in a variety of supplements and products. For more information visit www.forslean.com.
The Research and Development Council of New Jersey is a non-profit organization dedicated to cultivating an environment that supports the advancement of research and development throughout New Jersey. The Council is comprised of senior representatives from industry, academia and government. In fact, many R&D Council members represent today¹s Fortune 100 companies. For more information visit www.rdnj.org.
# # #